S
Scandinavian Medical Solutions A/S SMSMED.CO · DKK
Health Care · Nasdaq Copenhagen · 🇩🇰 Denmark
2.69
-3.24%
Close of 9 Nov 2026, in DKK
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in DKK, from our data supplier.
Revenue
DKK 245.4m
FY2019FY2025
Net income
DKK 26,000
FY2019FY2025
Free cash flow
−DKK 34.2m
FY2019FY2025
Shareholders' equity
DKK 82.7m
FY2019FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | DKK 245.4m | DKK 226.7m | DKK 191.2m | DKK 110.5m | DKK 71.6m | DKK 41.9m | DKK 31.2m |
| Gross profit | DKK 34.3m | DKK 40.1m | DKK 34.7m | DKK 22.7m | DKK 13.9m | DKK 7.4m | DKK 4.8m |
| Operating income | DKK 1.8m | DKK 13.8m | DKK 16.6m | DKK 14.7m | DKK 10.9m | DKK 6.0m | DKK 3.9m |
| Net income | DKK 26,000 | DKK 7.8m | DKK 12.2m | DKK 11.4m | DKK 8.2m | DKK 4.5m | DKK 3.0m |
| Diluted earnings per share | 0.00 | 0.28 | 0.45 | 0.42 | 0.31 | 45.11 | 0.11 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Total assets | DKK 205.9m | DKK 174.1m | DKK 164.0m | DKK 106.1m | DKK 44.6m | DKK 17.1m | DKK 9.4m |
| Cash and short-term investments | DKK 2.1m | DKK 11.0m | DKK 7.9m | DKK 27.8m | DKK 25.4m | DKK 10.7m | DKK 4.1m |
| Total liabilities | DKK 123.2m | DKK 91.6m | DKK 89.5m | DKK 43.9m | DKK 20.5m | DKK 12.2m | DKK 6.2m |
| Debt | DKK 63.5m | DKK 39.2m | DKK 28.6m | DKK 105,558 | — | DKK 302,405 | DKK 104,780 |
| Shareholders' equity | DKK 82.7m | DKK 82.5m | DKK 74.5m | DKK 62.2m | DKK 24.1m | DKK 4.9m | DKK 3.1m |
| Shares outstanding | 28m | 28m | 27m | 27m | 26m | 0m | 27m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Cash from operations | −DKK 13.4m | DKK 3.4m | −DKK 8.4m | −DKK 10.6m | DKK 4.0m | DKK 9.4m | — |
| Capital spending | −DKK 20.8m | −DKK 18.5m | −DKK 40.8m | −DKK 13.8m | −DKK 5 | −DKK 13.8m | — |
| Free cash flow | −DKK 34.2m | −DKK 15.1m | −DKK 49.2m | −DKK 24.3m | DKK 4.0m | −DKK 4.4m | — |
| Dividends paid | — | — | — | — | −DKK 4.5m | — | — |
Latest quarters
By quarter end
| Mar 2026 | Sept 2025 | Mar 2025 | Sept 2024 | Mar 2024 | Dec 2023 | Sept 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | DKK 92.3m | DKK 122.7m | DKK 122.7m | DKK 124.1m | DKK 102.6m | DKK 51.3m | DKK 95.0m | DKK 47.5m |
| Gross profit | −DKK 1.4m | DKK 16.1m | DKK 12.5m | DKK 17.3m | DKK 13.1m | DKK 8.7m | DKK 12.7m | DKK 6.9m |
| Operating income | −DKK 12.0m | DKK 5.3m | −DKK 3.4m | DKK 9.2m | DKK 4.6m | DKK 2.3m | DKK 3.9m | DKK 2.0m |
| Net income | −DKK 10.0m | DKK 2.4m | −DKK 2.3m | DKK 5.2m | DKK 2.6m | DKK 1.3m | DKK 2.7m | DKK 1.4m |
| Diluted earnings per share | -0.36 | 0.09 | -0.08 | 0.19 | 0.10 | 0.05 | 0.10 | 0.05 |
| Cash from operations | −DKK 2.0m | −DKK 1.0m | −DKK 11.0m | DKK 17.0m | −DKK 14.0m | −DKK 7.0m | DKK 2.0m | DKK 1.0m |
| Capital spending | −DKK 8.0m | −DKK 10.0m | −DKK 10.0m | −DKK 15.0m | −DKK 3.0m | −DKK 1.0m | −DKK 26.0m | −DKK 13.0m |
| Free cash flow | −DKK 10.0m | −DKK 11.0m | −DKK 21.0m | DKK 2.0m | −DKK 17.0m | −DKK 8.0m | −DKK 24.0m | −DKK 12.0m |
| Total assets | DKK 196.7m | DKK 205.9m | DKK 181.7m | DKK 174.1m | DKK 164.2m | DKK 164.2m | DKK 164.0m | DKK 164.0m |
| Cash and short-term investments | DKK 1.4m | DKK 2.1m | DKK 574,000 | DKK 11.0m | DKK 6.1m | DKK 6.1m | DKK 7.9m | DKK 7.9m |
| Debt | DKK 38.9m | DKK 33.2m | DKK 19.1m | DKK 25.9m | DKK 25.3m | DKK 25.3m | DKK 10.9m | DKK 10.9m |
| Shareholders' equity | DKK 72.8m | DKK 82.7m | DKK 80.4m | DKK 82.5m | DKK 77.3m | DKK 77.3m | DKK 74.5m | DKK 74.5m |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 30.2% | 42.3% | — |
| Operating income | -50.5% | -21.4% | — |
| Net income | -86.8% | -64.3% | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 15.8% | 17.0% | 17.2% | — |
| Operating margin | 3.3% | 6.1% | 7.2% | — |
| Net margin | 1.7% | 4.1% | 5.0% | — |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Price to earnings | — | 21.1 | 16.6 | 16.5 | 16.7 |
| Price to sales | 0.5 | 0.7 | 1.1 | 1.7 | 1.9 |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.